Abstract
Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.
Original language | English (US) |
---|---|
Pages (from-to) | 882-885 |
Number of pages | 4 |
Journal | Emerging infectious diseases |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2021 |
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases